Evidence map›Paper›PMID 41127051›Full record

ArticleJournal of transplantation2025

Older Kidney Transplant Patients Are Over Immunosuppressed Using Standard Protocols With Differential Sex-Based Complications.

Inji Alshaer, Rachel K Y Hung, Sumoyee Basu, Gabrielle Goldet, Gareth Jones, Mark Harber, Raymond Fernando, Ciara N Magee, Reza Motallebzadeh, Ben Caplin and 1 more

Abstract read
In one paragraph

Article in Journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Inji AlshaerUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.ORCID https://orcid.org/0000-0001-7489-0868
Rachel K Y HungUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Sumoyee BasuUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Gabrielle GoldetUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Gareth JonesUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Mark HarberUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Raymond FernandoUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Ciara N MageeUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Reza MotallebzadehUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Ben CaplinUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.
Alan D SalamaUCL Centre for Kidney and Bladder Health, Royal Free Hospital, London, UK.ORCID https://orcid.org/0000-0002-9255-9092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Increasing numbers of older patients are undergoing kidney transplantation. While there is evidence for both sex- and age-related immunological variations increasing the risks of immunosuppression (IS), few centers enforce age- or sex-specific IS adjustments. Methods: We investigated outcomes of 148 kidney transplants performed in our center between April 2009 and March 2019 in recipients aged > 60 years and compared them to outcomes in 272 younger recipients (divided into age groups 18-34, 35-49, and 50-60 years), matched for degree of human leukocyte antigen (HLA) sensitization (calculated reaction frequency, cRF), number of donor-recipient HLA mismatches, and cytomegalovirus (CMV) serostatus, all treated with the same IS protocol. Outcomes were time to (i) first episode of biopsy-proven acute rejection (BPAR), (ii) first CMV viremia within the first 6 months, (iii) incidence of any new-onset malignancy, and (iv) development of donor-specific anti-HLA antibodies (DSAs). Results: Overall rates of BPAR were highest in the recipients under the age of 35, but with no evidence of a difference between older age groups. Conversely, the risk of CMV viremia and malignancy was significantly higher in older recipients; in the > 60-year-old group, CMV viremia HR: 2.66 (95% CI: 1.49-4.75), and malignancy HR: 7.3 (95% CI: 1.7-31.10) versus the youngest group with little evidence was confounded by comorbidity or donor factors on multivariate analysis. The risk of CMV infection was most marked in the oldest female group, while the risk of malignancy was greatest in older males. The development of DSA was equal across all age groups. Conclusion: Our data indicate that older recipient age is associated with increased risk of CMV viremia and malignancy after transplantation, suggesting an age-associated vulnerability to IS, with the risk occurring mostly in older women and older men, respectively. These data support the need to develop age- and sex-specific protocol adjustments.

Indexed as

CMV infectionelderlyimmunosuppressionrejection

Identifiers

PMID41127051
PMCPMC12539993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.